Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.035 | 0.5 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |